Image credit: PublicDomainPictures from Pixabay 

The United States Congress is on its way to fund the Trump administration’s plan to end HIV by the year 2030.

According to the Washington Blade, Congress recently unveiled a $300 million spending package that will be divided between the Centers for Disease Control and Prevention, the Health Resources and Services Administration, and the Ryan White Health Care Act. Specifically, $70 million will go to the Ryan White Health Care Act, while $50 million will go to the Health Resources and Services Administration. Meanwhile, the Centers for Disease Control and Prevention will get the lion’s share of the funding, with $140 million allotted to them.

AIDS Institute deputy director and Presidential Advisory Council on HIV/AIDS co-chair Carl Schmid praised the agreement, saying it provided “the necessary foundational funding” to fulfill the administration’s plans.

“But in order for it to be successful, HIV prevention and treatment efforts will have to be scaled up dramatically, which will require both the administration and the Congress to support even greater funding increases in the future,” he said.

Kaiser Family Foundation director of global health and HIV policy Jennifer Kates is also quoted by the Washington Blade as saying that this funding should only be the beginning.

“As a first year installment, it represents a significant increase for these programs and should help to jump start the effort,” Kates said. “But it will be important to see what future funding requests are made, to fully reach targets.”

The funding is yet another positive development when it comes to the Trump administration’s plans with regard to HIV. Just a few weeks ago, the US government opened up applications for free PrEP by launching a website and a toll-free number. The free PrEP is itself the result of an agreement between the US government and the pharmaceutical company Gilead that would provide 2.4 million bottles of Truvada to 200,000 uninsured individuals.